StocksMedium•14 October 2026•
1 min read
Hims & Hers Health Faces Securities Fraud Class Action Lawsuit
Key Facts
1Hims & Hers Health faces a securities class action lawsuit following a federal complaint from the FTC alleging business misconduct.
Hims & Hers Health, Inc. and its executives are facing a securities class action lawsuit alleging fraud. GlobeNewswire reported that the legal action follows a federal complaint filed by the Federal Trade Commission (FTC) accusing the company of serious business misconduct, which triggered a sharp decline in its stock price and significant investor losses.
HIMS closed at $29.71 on October 13, 2026, after reaching a session high of $30.38 and a low of $28.72. The lawsuit focuses on whether the company misled investors regarding its business practices and internal controls, following the regulatory scrutiny initiated by the FTC's federal complaint.